This month our featured article is on the RACING trial, which compares the efficacy and safety of combination therapy of ezetimibe and moderate-intensity statin with monotherapy of high-intensity statin in patients with ASCVD.
Articles
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
Kim BK, Hong SJ, Lee YJ, et al.
Journal:
Lancet
First published: July 30, 2022 DOI: 10.1016/S0140-6736(22)00916-3